Generalized anxiety disorder (GAD) is a relatively prevalent and disabling condition. Duloxetine, an inhibitor of both serotonin and norepinephrine, was approved by the US FDA in 2007 for the treatment of GAD. Short-term efficacy of duloxetine in dosages of 60-120 mg/day has been established in four double-blind, placebo-controlled trials of 9-10 weeks duration. Duloxetine has also been found to meet rigorous criteria for noninferiority in comparison with venlafaxine in GAD. Duloxetine has shown superiority on measures of functioning and quality of life and, compared with placebo treatment, it reduces painful physical symptoms common in GAD patients. Continuation treatment for acute treatment responders was found to prevent relapse of GAD to a significantly greater degree than placebo. In all acute and long-term trials, duloxetine was well-tolerated. This body of research suggests that duloxetine should be one of the options considered as a first-line treatment for GAD.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1586/14737175.9.2.155 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Ear acupuncture with laser and needles in the treatment of anxiety in university students: a randomized clinical trial.
Rev Esc Enferm USP
January 2025
Universidade Federal de Viçosa, Departamento de Medicina e Enfermagem, Viçosa, MG, Brazil.
Objective: To compare the effectiveness of ear acupuncture with laser and needles in the treatment of anxiety in university students in the post-pandemic context of Covid-19, as well as to evaluate the possible symptoms or adverse reactions triggered by the interventions.
Method: Randomized clinical trial carried out with 126 university students, allocated to the "Needle" (control) and "Laser" (experimental) groups. Five ear acupuncture sessions were performed.
Anxiety and Depression Affect Sleep Quality: A Preliminary Investigation in Crowdsourced Samples of Autistic and Non-Autistic Adults.
J Autism Dev Disord
January 2025
Institutes for Behavior Resources, Inc, 2104 Maryland Ave., Baltimore, MD, 21218, USA.
We aimed to compare sleep problems in autistic and non-autistic adults with co-occurring depression and anxiety. The primary research question was whether autism status influences sleep quality, after accounting for the effects of depression and anxiety. We hypothesized that autistic adults would report higher levels of depression, anxiety, and sleep problems compared to non-autistic adults, after controlling for these covariates.
View Article and Find Full Text PDFAssociations between death anxiety and probable posttraumatic stress disorder and clinical depression and anxiety in older Israeli adults during wartime.
J Trauma Stress
January 2025
Department of Gerontology, University of Haifa, Haifa, Israel.
The outbreak of the Israel-Hamas war on October 7, 2023, has presented unprecedented challenges to older adults' mental health, including increased posttraumatic stress, anxiety, and depression. The current study examined potential war- and age-related factors associated with probable posttraumatic stress disorder (PTSD), clinical depression (probable depression), and generalized anxiety disorder (probable anxiety) among older adults during the ongoing war. Moreover, due to the continued threat of death, we examined whether death anxiety is an additional contributing factor to older adults' probable PTSD, depression, and anxiety.
View Article and Find Full Text PDFAssociation of depression dimensions with cognitive functioning in community-dwelling oldest old adults: The LifeAfter90 study.
J Gerontol B Psychol Sci Soc Sci
January 2025
Herbert and Jacqueline Krieger Klein Alzheimer's Research Center, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA.
Objectives: The oldest old adults (90+) constitute the fastest growing demographic at highest dementia risk among older adults. Depression, a common risk factor, inherently presents with heterogeneous clinical manifestations. Here, we explored the associations of the predominant depression dimensions with cognition in the LifeAfter90 study.
View Article and Find Full Text PDFDepression and anxiety symptoms among Afghan war widows and their associated factors: A cross-sectional analytical study.
Indian J Psychiatry
December 2024
Department of Global Health, McMaster University, Ontario, Canada.
Background: The 4 decades of conflict have particularly exacerbated the mental health of Afghan war widows, a population that has not been extensively studied in this context.
Aim: This study aims to fill the gap in the literature by providing robust data on the prevalence of depression and anxiety symptoms and identifying associated factors among Afghan war widows.
Methods: A cross-sectional study was carried out in 2023, interviewing war widows from four community health centers in Kandahar, Afghanistan.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!